IRAK1 and acute myeloid leukemia: Another study reported that innate immune pathway activation via the interleukin-1 receptor-associated kinase 1 and 4 (IRAK1/4) complex contributes to adaptive resistance in FLT3-mutant AML cells (Melgar et al. 2019).